Tower Research Capital LLC (TRC) - DECIBEL THERAPEUTICS INC ownership

DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of DECIBEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$11,038
+73486.7%
2,867
-43.7%
0.00%
Q1 2023$15
-25.0%
5,093
-49.0%
0.00%
-100.0%
Q4 2022$20
-100.0%
9,978
-14.7%
0.00%0.0%
Q3 2022$41,000
+1950.0%
11,698
+1799.0%
0.00%
Q2 2022$2,0000.0%616
-11.2%
0.00%
Q1 2022$2,000
-71.4%
694
-50.7%
0.00%
Q4 2021$7,000
-50.0%
1,409
+15.8%
0.00%
Q1 2021$14,0001,2170.00%
Other shareholders
DECIBEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATLAS CAPITAL ADVISORS LLC 40,000$36,4000.01%
View complete list of DECIBEL THERAPEUTICS INC shareholders